Massachusetts is one of about 40 states where someone who abuses drugs or alcohol to an extreme can be legally committed to a locked treatment facility. In most cases, a worried family member has to go to court to make that happen.
Children with certain medical conditions can now legally begin receiving medical marijuana in Connecticut. Governor Dannel Malloy signed legislation that extends the state’s medical marijuana program to minors for the first time.
Drug epidemics are not new in the United States. But there’s something very distinctive about the demographics of this latest wave, which centers around opioid and heroin abuse. It cuts across socio-economic and racial divides.
If you vote in Massachusetts, you’ve probably had a least one debate with a friend this year about whether the state should allow marijuana for recreational use.
But have you looked at the mechanics of the legal marijuana industry that ballot Question 4 would create? We’ve summarized key elements, in case you don’t have time to read all 24 pages of the proposed act before voting on Nov. 8.
Inmates with substance abuse issues face the highest risk of relapse, or fatal overdose, within the first few weeks of being released from incarceration. Research shows that 80 percent of former inmates with opiate dependence issues will relapse within a month of leaving jail.
Ken Aligata of the Connecticut Community for Addiction Recovery ran through an inspection of a sober living home in the quiet, picturesque neighborhood of Clinton, Connecticut. Seven people with addiction who are in recovery currently live there, and Aligata wants to make sure it’s a safe environment.
Patients and caregivers seeking the opioid-reversal drug naloxone can now get the medication without a doctor’s prescription. That’s thanks to a state law that went into effect one year ago allowing pharmacists to prescribe and dispense the drug.
Five states are voting this fall on whether marijuana should be legal, like alcohol, for recreational use. That has sparked questions about what we know — and don't know — about marijuana's effect on the brain.
Connecticut's medical marijuana program is proving to be a success. The program has been up and running since 2014 with more than 12,000 patients and a growing list of certified doctors, according to the Department of Consumer Protection.
A powerful drug that's normally used to tranquilize elephants is being blamed for a record spike in drug overdoses in the Midwest. Officials in Ohio have declared a public health emergency, and the U.S. Drug Enforcement Administration says communities everywhere should be on alert for carfentanil.
The synthetic opioid is 100 times more potent than fentanyl, the prescription painkiller that led to the death earlier this year of the pop star Prince. Fentanyl itself can be up to 50 times more deadly than heroin.
Four years ago, Connecticut became the 17th state to legalize medical marijuana. By 2014, the state officially launched its medical marijuana program, making it possible for card-holding patients to buy the drug legally. This hour, we get an update on that program from Connecticut's Department of Consumer Protection Commissioner Jonathan Harris. We also hear from a Connecticut woman who saw how the program helped her husband, and we check in with doctors and dispensaries in the state.
Why are some people more susceptible to addiction than others? How does genetic makeup influence a person’s chances of becoming an addict? This hour, we find out how researchers at Yale University and The Jackson Laboratory are working to better understand the science of addiction.
When Phillip decided to stop using heroin, he knew sticking around home was a recipe for failure.
"It's just, like, a heroin epidemic on Long Island where I'm from. So I had to get away from that and now I'm in Prescott, Ariz.," Phillip says. NPR agreed not to use his last name because he is struggling with addiction and fears it might hurt his chances of future employment.